TABLE 1.
Scientific name | Main active ingredients | Main indications | Mechanism of action | References |
---|---|---|---|---|
Lavender (Lavandula angustifolia Mill.) Essential Oil | Linalyl acetate, linalool, (E)-β- stilbene, limonene | Anxiety Depression Sleep disorder | ↑: Parasympathetic nervous system | López et al. (2017); Ozkaraman et al. (2018) ; Mahdavikian et al. (2020); Kim M. et al. (2021) |
↑: Dopamine receptors subtype D3 | ||||
↑: Alpha waves in the brain | ||||
↓: NMDA receptors | ||||
↓: Serotonin transporter (SERT) | ||||
Roman Chamomile (Chamaemelum nobile L.) Essential Oil | Angelic acid, tiglic acid, α-pinene, and 2-methyl butanoic acid | Anxiety Depression Sleep disorder | ↑: Mitochondrial function | Kong et al. (2017); Ebrahimi et al. (2021); Jia et al. (2021) |
↑: Expression of parvalbumin mRNA in hippocampus | ||||
↑: Neuroactive ligand- receptor interactions | ||||
↑: 5-hydroxytryptamine | ||||
synapses | ||||
Bergamot (Citrus bergamia Risso et Poiteau) Essential Oil | Monoterpenes limonene, monoterpene esters, linalyl acetate, and linalool | Anxiety Depression Sleep disorder | ↑: Synaptic transmission | Costa et al. (2010); Donato et al. (2014); Watanabe et al. (2015); Rombolà et al. (2017) |
↑: EEG activity | ||||
↑: Neuroprotective effects | ||||
Lemon Balm (Melissa officinalis L.) Essential Oil | Citral, citronellal, linalool, geraniol and β-caryophyllene-oxide | Anxiety Depression Fatigue | ↑: Dopamine | Komiya et al. (2006) |
↑: Serotonin | ||||
Saint John’s wort (Hypericum perforatum L.) extracts | Germacrene D, (E)-caryophyllene, 2-methyl octane, α-pinene, hypericin, proto-hypericin | Anxiety Depression Sleep disorder | ↑: Serotonergic system | Wong et al. (2004); Linde et al. (2008); Di Pierro et al. (2018) |
↓: Monoamine neurotransmitters | ||||
Rhodiola rosea L. (R. rosea L.) extracts | Cinnamyl alcohol glycosides such as rosin, rosavin, and the phenylethanoid compound salidroside with its aglycone tyrosol | Anxiety Depression Sleep disorder Fatigue | ↑: Neurotransmitters | Panossian et al. (2010); Alperth et al. (2019); Panossian et al. (2021); Kim K. J. et al. (2021) |
↑: BDNF/TrkB signaling pathway | ||||
↓: Anti-inflammatory action | ||||
↓: Glucocorticoid receptor | ||||
↓: Activity of HPA axis | ||||
Cang-ai volatile oil | Eugenol, 1,8-cineole, patchouli alcohol, acetyl eugenol, linalool, linalyl acetate | Depression | ↑: Dopamine | Chen et al. (2019) |
↑: 5-hydroxytryptamine |
↑, enhance, activate or increase; ↓, weaken, inactivate or decrease.